Caladrius Biosciences

Nov 12, 2019

AIVITA Biomedical Announces New Positive Phase 2 Glioblastoma Data at SITC Annual Meeting Podium Presentation

Sep 30, 2019

Visiongain Report Claims there is Huge Potential Within the $28bn Stem Cell Technologies and Applications Market

May 06, 2019

Neuralstem Appoints David J. Mazzo, Ph.D., to Board of Directors

Feb 21, 2019

AIVITA Completes Treatment of First Patient in Phase 2 Ovarian Cancer Trial

Oct 12, 2018

AIVITA Biomedical Attains Japanese PMDA Milestone for ROOT OF CANCER Technology

Sep 20, 2018

AIVITA Biomedical Announces Treatment of First Patient in Phase 2 Ovarian Cancer Trial

Jun 14, 2018

AIVITA Biomedical Randomizes First Patient in Phase II Ovarian Cancer Trial

Mar 20, 2018

Healthcare Companies Capitalizing on a Resurgent Biotech Industry

Jan 30, 2018

EMA grants Rexgenero's Lead Product REX-001 Advanced Therapy Medicinal Product Certificate for Manufacturing Quality and Non-clinical Data

Jun 14, 2017

Invetech and Caladrius Biosciences Receive 2017 Good Design Award® for Design of a Counterflow Centrifuge Device for use in the Development of Cell Therapies